Vitae Pharmaceuticals, Inc. (Nasdaq: VTAE) today announced positive top-line results from clinical trials in treatment and prevention of Alzheimer's disease ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE